Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 126 | 121 | −5 |
| Shares | 60.4M | 64.8M | +4.43M (+7.3%) |
| Value | $569.7M | $402.0M | −$167.7M (−29.4%) |
New holders (31)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (36)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.